Skip to main content

FDA recall, , Moderate risk

Agebox iKids-Growth Day and Night Formula Capsules

Agebox iKids-Growth (Day Formula) capsules contain undeclared ibutamoren.

What happened

Agebox of Wilmington, Delaware is recalling iKids-Growth (Night Formula) and iKids-Growth (Day Formula) capsules because they contain undeclared ibutamoren and were marketed without an approved NDA/ANDA. The recall began on October 28, 2025, and the products were distributed nationwide in the United States through Agebox.com and Amazon.com.

2 photos

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is your bottle affected?

2 products

Match the list below, then check the codes the FDA notice also names.

A UPC is the number printed under a barcode.

  1. Agebox iKids-Growth (Day Formula) capsules, 60-count bottles

    UPC
    • 23101201
    • 24080801
    • 25020701
  2. Agebox iKids-Growth (Night Formula), 60-count bottles

    UPC
    • 23101202
    • 24080802
    • 25020702

From the FDA notice

Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX Inc., Wilmington, DE 19801 USA, UPC 8 50065 59701 0

Recall details

Company began the recall
Sold in

The product was distributed nationwide in the U.S. Agebox sells its U.S. products through Agebox.com (using Shopify) and Amazon.com. All orders are shipped to customers by Agebox itself; other parties are not involved in the distribution of the physical product.

Company
AgeboxWilmington, Delaware
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98011
Recall numbers
D-0344-2026 to D-0345-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)